Anavex Life Sciences Corp. Stock News

Anavex Life Sciences press release (AVXL): FQ1 GAAP EPS of -$0.14.Cash and cash equivalents of $151.1 million on December 31, 2021, compared to $152.1 million on September 30, 2021.

Company to host a webcast today at 4:30 p.m. Eastern Time

Companies Reporting Before The Bell Equinor (NYSE: EQNR ) is projected to report quarterly earnings at $0.63 per share on revenue of $25.05 billion. ICL Group (NYSE: ICL ) is expected to report quarterly earnings at $0.13 per share on revenue of $1.82 billion. Madison Square Garden (NYSE: MSGE ) is projected to report quarterly earnings at $1.00 per share on revenue of $538.98 million. Anavex Life Sciences (NASDAQ: AVXL ) is likely to report earnings for its first quarter. Orion Energy Sys (NASDAQ: OESX ) is likely to report quarterly earnings at $0.04 per share on revenue of $32.86 million. Penske Automotive Group (NYSE: PAG ) is estimated to report quarterly earnings at $3.69 per share on revenue of $6.22 billion. Mastech Digital (AMEX: MHH ) is projected to report quarterly earnings at $0.38 per share on revenue of $59.90 million. Perion Network (NASDAQ: PERI ) is projected to report quarterly earnings at $0.39 per share on revenue of $144.96 million. Ares Capital (NASDAQ: ARCC ) is estimated to report quarterly earnings at $0.49 per share on revenue of $459.14 million. Lithia Motors (NYSE: LAD ) is expected to report quarterly earnings at $10.14 per share on revenue of $6.15 billion. Cameco (NYSE: CCJ ) is expected to report quarterly earnings at $0.03 per share on revenue of $362.39 million. CDW (NASDAQ: CDW ) is expected to report quarterly earnings at $1.92 per share on revenue of $5.18 billion. Bunge (NYSE: BG ) is projected to report quarterly earnings at $2.55 per share on revenue of $13.61 billion. Yum Brands (NYSE: YUM ) is likely to report quarterly earnings at $1.09 per share on revenue of $1.88 billion. Crown Crafts (NASDAQ: CRWS ) is likely to report quarterly earnings at $0.24 per share on revenue of $18.80 million.

Most treatments for Alzheimer's disease either lead to only temporary improvements or only minimally slow down the progression of the disease. Read what makes investors positive on Anavex...

Anavex Life Sciences (NASDAQ:AVXL) is scheduled to announce Q1 earnings results on Tuesday, February 8th, after market close.The consensus EPS Estimate is -$0.16 (-33.3% Y/Y) and…

Anavex Life Sciences (AVXL), a clinical-stage biopharmaceutical Co., provides supplemental information on the ANAVEX®2-73 AVATAR Phase 3 trial for the treatment of adult patients with

NEW YORK, Feb. 04, 2022 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therap

Webcast and Conference Call To be Held Wednesday, February 9, 2022, 4:30 pm ET Webcast and Conference Call To be Held Wednesday, February 9, 2022, 4:30 pm ET

AVXL reported positive topline data from their trial for Rett syndrome in adults on Feb 1, 2022. However, the results were met with much skepticism or cynicism, due to changes to the trial's endpoints

Webcast and Conference Call To be Held Wednesday, February 9, 2022, 4:30 pm ET Webcast and Conference Call To be Held Wednesday, February 9, 2022, 4:30 pm ET

Anavex: Misunderstood Data And Possible Positive FDA Meeting Can Lead To Great Trade Opportunity

Biofrontera (BFRI) +14%. Synaptogenix (SNPX) +11%. Sio Gene Therapies (SIOX) -19%. Anavex Life Sciences (AVXL) -16%.

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus ImmunityBio Announces Positive Phase 1 Data For Anktiva In HIV ImmunityBio, Inc. (NASDAQ: IBRX) announ

The stock price of Anavex Life Sciences Corp (NASDAQ: AVXL) fell by over 13% during intraday trading today. This is why it happened.